Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$511M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$442M |
| 3 |
Microsoft
MSFT
|
+$392M |
| 4 |
Amazon
AMZN
|
+$348M |
| 5 |
Corteva
CTVA
|
+$288M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$419M |
| 2 |
Cisco
CSCO
|
+$141M |
| 3 |
Altria Group
MO
|
+$135M |
| 4 |
TJX Companies
TJX
|
+$114M |
| 5 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.3% |
| 2 | Financials | 15.46% |
| 3 | Healthcare | 13.81% |
| 4 | Consumer Discretionary | 10.38% |
| 5 | Industrials | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVFM
2951
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $1.88M | ﹤0.01% |
18,826
+13,863
| +279% | +$1.07M |
|
|
SCWX
2952
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $1.87M | ﹤0.01% |
140,630
+5,570
| +4% | +$92.6K |
|
2953
Anavex Life Sciences
AVXL
$324M
| $1.86M | ﹤0.01% |
551,763
+222,915
| +68% | +$692K |
|
2954
Bristow Group
VTOL
$1.37B
| $1.86M | ﹤0.01% |
111,435
+4,279
| +4% | +$76.5K |
|
|
SEVN
2955
Seven Hills Realty Trust
SEVN
$173M
| $1.86M | ﹤0.01% |
101,339
-8,351
| -8% | -$155K |
|
2956
AXT Inc
AXTI
$5.24B
| $1.86M | ﹤0.01% |
468,913
+55,836
| +14% | +$261K |
|
|
TCFC
2957
DELISTED
The Community Financial Corporation Common Stock
TCFC
| $1.85M | ﹤0.01% |
54,937
+12,147
| +28% | +$372K |
|
|
BWG
2958
BrandywineGLOBAL Global Income Opportunities Fund
BWG
$131M
| $1.85M | ﹤0.01% |
157,840
+44,468
| +39% | +$499K |
|
2959
Cue Biopharma
CUE
$116M
| $1.84M | ﹤0.01% |
6,838
+1,965
| +40% | +$489K |
|
|
CALA
2960
DELISTED
Calithera Biosciences, Inc
CALA
| $1.84M | ﹤0.01% |
23,636
+3,156
| +15% | +$358K |
|
|
NPTN
2961
DELISTED
NEOPHOTONICS CORP
NPTN
| $1.83M | ﹤0.01% |
438,919
+45,607
| +12% | +$240K |
|
2962
Arcus Biosciences
RCUS
$3.68B
| $1.83M | ﹤0.01% |
230,355
+27,360
| +13% | +$274K |
|
|
SBBX
2963
DELISTED
SB One Bancorp Common Stock
SBBX
| $1.83M | ﹤0.01% |
81,883
+10,909
| +15% | +$246K |
|
|
CHAP
2964
DELISTED
Chaparral Energy, Inc.
CHAP
| $1.82M | ﹤0.01% |
387,538
+146,353
| +61% | +$732K |
|
|
SYBX
2965
DELISTED
Synlogic
SYBX
| $1.82M | ﹤0.01% |
13,356
+2,337
| +21% | +$285K |
|
2966
Aldeyra Therapeutics
ALDX
$92.3M
| $1.82M | ﹤0.01% |
303,789
+29,341
| +11% | +$221K |
|
2967
CRISPR Therapeutics
CRSP
$5.21B
| $1.82M | ﹤0.01% |
38,700
+112
| +0.3% | +$4.48K |
|
2968
Precision BioSciences
DTIL
$206M
| $1.82M | ﹤0.01% |
+4,579
| New | +$1.84M |
|
|
OSG
2969
DELISTED
Overseas Shipholding Group Inc.
OSG
| $1.81M | ﹤0.01% |
961,709
+27,845
| +3% | +$51.6K |
|
|
PAMT
2970
PAMT Corp
PAMT
$269M
| $1.8M | ﹤0.01% |
116,428
+6,156
| +6% | +$83.9K |
|
2971
Oil-Dri
ODC
$1.27B
| $1.8M | ﹤0.01% |
105,940
+15,304
| +17% | +$239K |
|
|
CGC
2972
Canopy Growth
CGC
$435M
| $1.8M | ﹤0.01% |
4,611
+1,280
| +38% | +$563K |
|
2973
Palomar
PLMR
$3.39B
| $1.8M | ﹤0.01% |
+74,955
| New | +$1.65M |
|
2974
Union Bankshares
UNB
$118M
| $1.8M | ﹤0.01% |
48,558
+3,320
| +7% | +$125K |
|
2975
Fastly Inc
FSLY
$4.63B
| $1.8M | ﹤0.01% |
+88,587
| New | +$1.82M |
|
Similar funds
Geode Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Geode Capital Management held 4,308 positions worth $413B, up 7.1% from $386B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Geode Capital Management deployed $13.5B of net new capital in Q2 2019, opening 177 new positions and adding to 3,043 existing holdings. Its largest new stake was Dow Inc: 9,682,103 shares worth $477M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was DuPont de Nemours, an estimated $419M trimmed.
- Geode Capital Management's largest Q2 2019 buy was Dow Inc: 9,682,103 shares worth $477M.
- Geode Capital Management added most to Alphabet (Google) Class A in Q2 2019, an estimated $442M increase.
- Geode Capital Management's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $419M.
- Geode Capital Management fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $109M.
- Geode Capital Management's ten largest holdings make up 17% of its $413B portfolio in Q2 2019.
- Geode Capital Management opened 177 new positions and closed 101 in Q2 2019.
- Geode Capital Management's portfolio value rose 7.1% quarter-over-quarter to $413B.
Based on Geode Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.